相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Immune responses following third COVID-19 vaccination are reduced in patients with hematological compared to patients with solid cancer
Annika Fendler et al.
CANCER CELL (2022)
Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer
Annika Fendler et al.
LANCET (2022)
Immunogenicity and safety of BNT162b2 mRNA vaccine booster in actively treated patients with cancer
Hagai Ligumsky et al.
LANCET ONCOLOGY (2022)
Divergent SARS-CoV-2 Omicron-reactive T and B cell responses in COVID-19 vaccine recipients
Corine H. GeurtsvanKessel et al.
SCIENCE IMMUNOLOGY (2022)
COVID-19 vaccination and breakthrough infections in patients with cancer
A. L. Schmidt et al.
ANNALS OF ONCOLOGY (2022)
COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety
Annika Fendler et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2022)
mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial
Sjoukje F. Oosting et al.
LANCET ONCOLOGY (2021)
Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
Einav G. Levin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment
M. Peeters et al.
ESMO OPEN (2021)